Story · Medicine & Biotech
Saad Usmani: ASH 2026 Highlights Emerging Immunotherapy Strategies in Multiple Myeloma
1 outlet · first reported by OncoDaily on
Saad Usmani, Chief of the Myeloma Service at Memorial Sloan Kettering Cancer Center and Professor of Clinical Medicine at Weill Cornell Medical College, shared on X: “The Best of ASH (OncoDaily)
Coverage, in order
-
Saad Usmani: ASH 2026 Highlights Emerging Immunotherapy Strategies in Multiple MyelomaSaad Usmani, Chief of the Myeloma Service at Memorial Sloan Kettering Cancer Center and Professor of Clinical Medicine at Weill Cornell Medical College, shared on X: “The Best of ASH
Alivewire groups outlets reporting the same story. Each headline links to the outlet that wrote it; nothing is republished here.